Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.
A large repository of cryopreserved peripheral blood mononuclear cells (PBMCs) samples was created to provide laboratories testing the specimens from human immunodeficiency virus-1 (HIV-1) vaccine clinical trials the material for assay development, optimization, and validation. One hundred thirty-one PBMC samples were collected using leukapheresis procedure between 2007 and 2013 by the Comprehensive T cell Vaccine Immune Monitoring Consortium core repository. The donors included 83 human immunodeficiency virus-1 (HIV-1) seronegative and 32 HIV-1 seropositive subjects. The samples were extensively characterized for the ability of T cell subsets to respond to recall viral antigens including cytomegalovirus, Epstein-Barr virus, influenza virus, and HIV-1 using Interferon-gamma (IFN-γ) enzyme linked immunospot (ELISpot) and IFN-γ/interleukin 2 (IL-2) intracellular cytokine staining (ICS) assays. A subset of samples was evaluated over time to determine the integrity of the cryopreserved samples in relation to recovery, viability, and functionality. The principal results of our study demonstrate that viable and functional cells were consistently recovered from the cryopreserved samples. Therefore, we determined that this repository of large size cryopreserved cellular samples constitutes a unique resource for laboratories that are involved in optimization and validation of assays to evaluate T, B, and NK cellular functions in the context of clinical trials.
Foundation for National Institutes of Health, Bethesda, MD, USA.
Anna
A
Sambor
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA.
Ambrosia
A
Garcia
Duke University Medical Center, Durham, NC, USA.
Mark
M
Berrong
Duke University Medical Center, Durham, NC, USA.
Joy
J
Pickeral
Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
Sara
S
Brown
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA.
Wes
W
Rountree
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA.
Ana
A
Sanchez
Duke University Medical Center, Durham, NC, USA.
Justin
J
Pollara
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nicole
N
Frahm
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA.
Sarah
S
Keinonen
Viral Genetics Section, US Military HIV Research Program, Henry M Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Gustavo H
GH
Kijak
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
Mario
M
Roederer
Foundation for National Institutes of Health, Bethesda, MD, USA.
Gail
G
Levine
Division of AIDS, NIAD, NIH, Rockville, MD, USA.
M Patricia
MP
D'Souza
Becton Dickinson, San Jose, CA, USA.
Maria
M
Jaimes
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
Richard
R
Koup
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA.
Thomas
T
Denny
International AIDS Vaccine Initiative, New York, NY, USA.
Josephine
J
Cox
Duke Human Vaccine Institute, Duke University, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA. Electronic address: gflmp@duke.edu.
Guido
G
Ferrari
D016915:AIDS Vaccines / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D018070:Biological Specimen Banks / Q000592:standards*; D015415:Biomarkers / Q000097:blood; D002470:Cell Survival; D003299:Cooperative Behavior; D015925:Cryopreservation / Q000592:standards; D016207:Cytokines / Q000097:blood; D058501:Enzyme-Linked Immunospot Assay / Q000592:standards; D005260:Female; D019983:Guideline Adherence / Q000592:standards; D015658:HIV Infections / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007159:Immunologic Tests / Q000592:standards*; D059425:Interferon-gamma Release Tests / Q000592:standards; D007391:International Cooperation; D059021:Laboratory Proficiency Testing / Q000592:standards*; D007937:Leukapheresis / Q000592:standards; D007963:Leukocytes, Mononuclear / Q000276:immunology* / Q000821:virology; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic / Q000592:standards*; D015588:Observer Variation; D017410:Practice Guidelines as Topic / Q000592:standards; D011237:Predictive Value of Tests; D011786:Quality Control; D019984:Quality Indicators, Health Care / Q000592:standards*; D015203:Reproducibility of Results; D013048:Specimen Handling / Q000592:standards; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D016915:AIDS Vaccines; D015415:Biomarkers; D016207:Cytokines
Cryopreservation; Peripheral blood mononuclear cells; Repository